.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Accenture
McKesson
Cantor Fitzgerald
Queensland Health
Argus Health
Mallinckrodt
Julphar
Dow
Cerilliant

Generated: July 26, 2017

DrugPatentWatch Database Preview

PHRENILIN Drug Profile

« Back to Dashboard

What is the patent landscape for Phrenilin, and when can generic versions of Phrenilin launch?

Phrenilin is a drug marketed by Valeant and is included in three NDAs.

The generic ingredient in PHRENILIN is acetaminophen; butalbital; caffeine; codeine phosphate. There are sixty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine; codeine phosphate profile page.

Summary for Tradename: PHRENILIN

Patents:0
Applicants:1
NDAs:3
Bulk Api Vendors: see list98
Patent Applications: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PHRENILIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant
PHRENILIN
acetaminophen; butalbital
TABLET;ORAL087811-001Jun 19, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Valeant
PHRENILIN FORTE
acetaminophen; butalbital
CAPSULE;ORAL088831-001Jun 19, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Valeant
PHRENILIN WITH CAFFEINE AND CODEINE
acetaminophen; butalbital; caffeine; codeine phosphate
CAPSULE;ORAL074911-001Aug 22, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Fish and Richardson
Novartis
McKesson
QuintilesIMS
UBS
Citi
Julphar
Medtronic
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot